Nanoscale Modulation of the Pore Dimensions, Size Distribution and Structure of a new Polysulfone-Based High-Flux Dialysis Membrane
暂无分享,去创建一个
[1] A. Cheung,et al. The hemodialysis membranes: a historical perspective, current state and future prospect. , 1997, Seminars in nephrology.
[2] W. Hörl. Are new toxins appearing on the horizon? , 2001, Contributions to nephrology.
[3] Shin-ichi Nakao,et al. Determination of pore size and pore size distribution: 3. Filtration membranes , 1994 .
[4] M J Lysaght,et al. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. , 1999, Kidney international.
[5] R. Wolfe,et al. Relationship of dialysis membrane and cause-specific mortality. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] M. Mulder. Characterisation of Membranes , 1991 .
[7] M Arakawa,et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.
[8] C. Ronco,et al. Dialysis membranes in convective treatments. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] R. Wolfe,et al. Trends in treatment and survival for hemodialysis patients in the United States. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] A. Cheung,et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] Willy Lornoy,et al. Remarkable Removal of Beta-2-Microglobulin by On-Line Hemodiafiltration , 1998, American Journal of Nephrology.
[12] R. Fischer,et al. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Claudio Ronco,et al. Does Nanotechnology Apply to Dialysis? , 2001, Blood Purification.
[14] R. Vanholder,et al. Redesigning the map of uremic toxins. , 2001, Contributions to nephrology.
[15] I Ledebo,et al. Principles and practice of hemofiltration and hemodiafiltration. , 1998, Artificial organs.
[16] R. Vanholder,et al. Pathophysiologic effects of uremic retention solutes. , 1999, Journal of the American Society of Nephrology : JASN.
[17] C Ronco,et al. Hemodiafiltration with online regeneration of the ultrafiltrate. , 2000, Kidney international. Supplement.
[18] C. Ronco,et al. Factors Affecting Hemodialysis and Peritoneal Dialysis Efficiency , 2001, Seminars in dialysis.